Cell-Free DNA Fragmentomics in Liquid Biopsy

Area of Science:

• Biochemistry
• Molecular Biology
• Genomics

Background:

• Cell-free DNA (cfDNA) in bodily fluids is crucial for noninvasive diagnostics like prenatal testing, cancer liquid biopsies, and transplant monitoring.
• Plasma cfDNA comprises a mix of molecules from various tissues, making its origin analysis challenging.
• Fragmentomics, the study of cfDNA fragmentation patterns, is a rapidly advancing area for biomarker discovery.

Purpose of the Study:

• To review recent biological insights into cfDNA fragmentation.
• To explore the potential clinical applications of fragmentomic markers.

Main Methods:

• Analysis of cfDNA size distribution differences between tissue origins (fetal, tumor, transplanted liver vs. hematopoietic).
• Identification of novel fragmentomic markers: fragment sizes, preferred ends, end motifs, jagged ends, and nucleosomal footprints.
• Investigation of the biological link between DNA nuclease activity and cfDNA fragmentation characteristics.

Main Results:

• cfDNA molecules from fetal, tumor, and transplanted liver sources exhibit distinct size distributions compared to background cfDNA.
• Emerging fragmentomic markers provide deeper insights into cfDNA origins.
• A direct biological relationship exists between DNA nuclease activities and specific cfDNA fragmentation patterns.

Conclusions:

• cfDNA fragmentation patterns contain significant biological information about the tissue of origin.
• Fragmentomics presents a promising frontier for developing novel noninvasive diagnostic and monitoring tools.
• Further research into cfDNA biological properties and fragmentomics will enhance clinical utility.